Kos Pharmaceuticals Inc Sample Contracts

RECITALS
Employment Agreement • December 17th, 1996 • Kos Pharmaceuticals Inc
AutoNDA by SimpleDocs
WITNESSETH
Lease Agreement • December 17th, 1996 • Kos Pharmaceuticals Inc • Florida
UNDERWRITING AGREEMENT
Underwriting Agreement • October 20th, 1997 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • New York
WITNESSETH:
Lease Agreement • December 17th, 1996 • Kos Pharmaceuticals Inc
RECITALS
Employment Agreement • September 2nd, 1997 • Kos Pharmaceuticals Inc • Pharmaceutical preparations
RECITALS
License Agreement • March 6th, 1997 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • Florida
RECITALS
Employment Agreement • December 17th, 1996 • Kos Pharmaceuticals Inc
BACKGROUND:
Master Services Agreement • March 29th, 2002 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • New York
COMMON STOCK (PAR VALUE $.01 PER SHARE)
Underwriting Agreement • November 20th, 2003 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • New York
WITNESSETH
Lease Agreement • December 17th, 1996 • Kos Pharmaceuticals Inc • Florida
April 27, 1998 COMMITMENT LETTER
Commitment Letter • May 14th, 1998 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
RECITALS
Registration Rights Agreement • March 23rd, 2000 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
WITNESSETH:
Lease Agreement • December 17th, 1996 • Kos Pharmaceuticals Inc
ARTICLE I DEFINITIONS
Revolving Credit and Loan Agreement • March 26th, 2003 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • New York
AutoNDA by SimpleDocs
RECITALS
Modification and Extension Agreement • December 17th, 1996 • Kos Pharmaceuticals Inc
Contract
Change in Control Severance Agreement • November 7th, 2006 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey

[FORM OF] CHANGE IN CONTROL SEVERANCE AGREEMENT (this “Agreement”) dated as of [•], between Kos Pharmaceuticals, Inc., a Florida corporation (the “Company”), and [NAME] (the “Executive”).

RECITALS
Registration Rights Agreement • March 26th, 2003 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • Florida
AGREEMENT AND PLAN OF MERGER among ABBOTT LABORATORIES, S&G NUTRITIONALS, INC. and KOS PHARMACEUTICALS, INC. Dated as of November 5, 2006
Merger Agreement • November 7th, 2006 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • Delaware

AGREEMENT AND PLAN OF MERGER, dated as of November 5, 2006 (this “Agreement”) among ABBOTT LABORATORIES, an Illinois corporation (“Parent”), S&G Nutritionals, Inc., a Delaware corporation and a direct wholly-owned Subsidiary of Parent (“Merger Sub”), and KOS PHARMACEUTICALS, INC., a Florida corporation (the “Company”).

SHAREHOLDERS AGREEMENT
Shareholders Agreement • November 7th, 2006 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • Delaware

SHAREHOLDERS AGREEMENT, dated as of November 5, 2006 (this “Agreement”), by and between ABBOTT LABORATORIES, an Illinois corporation (“Parent”), on the one hand, and Michael Jaharis, Mary Jaharis, Kathryn Jaharis, Steven Jaharis, Wilson Point Holdings, LP, Kos Investments, Inc., Cubs Management, LLC, Kos Holdings, Inc., Jaharis Holdings, LLC, Steven Jaharis Generational Trust, 2002 Mary Jaharis Grantor Retained Annuity Trust 2, Michael and Mary Jaharis Alaska Community Property Trust, Kathryn Jaharis and Richard Ledes Joint Account, the Jaharis Family Foundation, Inc. and Michael Steven Jaharis Trust 1 (collectively, the “Shareholders”), on the other hand. Capitalized terms used but not defined herein shall have the meanings given to such terms in the Merger Agreement.

CONFIDENTIAL MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS. Collaboration and License Agreement
Collaboration and License Agreement • September 14th, 2006 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • New York

This agreement (“Agreement”) is made and entered into as of November 6, 2005 (the “Execution Date”), by and between Jerini US, Inc., a Delaware corporation (“Jerini”), and Kos Life Sciences, Inc., a Delaware corporation (“Kos”). Jerini and Kos each may be referred to herein individually as a “Party,” or collectively as the “Parties.”

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!